Clinical Trials Directory

Trials / Completed

CompletedNCT04722354

Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
5 (actual)
Sponsor
AdventHealth Translational Research Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effects of oral abscisic acid (ABA) on glucose metabolism in subjects with defined prediabetes.

Conditions

Interventions

TypeNameDescription
OTHERHyperinsulemic euglycemic clampFollowing a 12-hour overnight fast at the CRU (including abstinence from caffeine containing foods and beverages), insulin sensitivity will be measured using the criterion method of the euglycemic clamp. Participants will have not performed vigorous physical activity for at least the previous 24 h, and be free of acute illness for the prior 2 weeks. An intravenous catheter will be placed in an antecubital vein for subsequent insulin (40 mU/m2-min) and glucose infusions and for stable isotope (6, 6-2H2) infusions to measure insulin sensitivity.
PROCEDUREMuscle BiopsyOne biopsy taken prior to clamp and a second biopsy taken 30-45 min after the start of the clamp. A biopsy of the Vastus Lateralis muscle will be performed on the leg/thigh using the Bergstrom technique.
DIETARY_SUPPLEMENTOral abscisic acid (ABA)Those in this group will receive ABA (95 µg ABA and 300 mg of corn starch)
OTHERPlaceboThose in this group will receive placebo (300 mg cornstarch)

Timeline

Start date
2021-03-08
Primary completion
2024-08-26
Completion
2025-12-01
First posted
2021-01-25
Last updated
2026-03-09
Results posted
2026-03-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04722354. Inclusion in this directory is not an endorsement.